Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changjun Wang

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
Journal of Bacteriology|February 3, 2009
The orphan response regulator CovR: a globally negative modulator of virulence in Streptococcus suis serotype 2Xiuzhen Pan, Junchao Ge, Ming Li, et al.
Environmental Microbiology|August 4, 2021
Environmental contamination with SARS-CoV-2 in COVID-19 hospitals in Wuhan, China, 2020Wei Liu, Dingchen Li, Chaojie Yang, et al.
Annals of Internal Medicine|May 5, 2025
Thyroid Function Reference Intervals by Age, Sex, and Race : A Cross-Sectional StudyQihang Li, Yida Tang, Xuefeng Yu, et al.
Radiology|June 1, 2021
Percutaneous Transhepatic Papillary Balloon Dilation versus Endoscopic Retrograde Cholangiopancreatography for Common Bile Duct Stones: A Multicenter Prospective StudyBin Liu, Jijun Ma, Shengyong Li, et al.
Blood|June 24, 2020
Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusionXinyi Xia, Kening Li, Lingxiang Wu, et al.
Nature Cell Biology|June 5, 2019
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilitiesJean-Philippe Coppé, Miki Mori, Bo Pan, et al.
Plos Medicine|April 6, 2006
Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2Jiaqi Tang, Changjun Wang, Youjun Feng, et al.
Cell Discovery|September 1, 2021
Genome-wide association study of COVID-19 severity among the Chinese populationYuanfeng Li, Yuehua Ke, Xinyi Xia, et al.
Plos One|March 22, 2007
A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolatesChen Chen, Jiaqi Tang, Wei Dong, et al.
Nature Cancer|February 9, 2023
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF<sup>V600E</sup> colorectal tumorsAna Ruiz-Saenz, Chloe E Atreya, Changjun Wang, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Journal of Bacteriology|February 3, 2009
The orphan response regulator CovR: a globally negative modulator of virulence in Streptococcus suis serotype 2Xiuzhen Pan, Junchao Ge, Ming Li, et al.
Environmental Microbiology|August 4, 2021
Environmental contamination with SARS-CoV-2 in COVID-19 hospitals in Wuhan, China, 2020Wei Liu, Dingchen Li, Chaojie Yang, et al.
Annals of Internal Medicine|May 5, 2025
Thyroid Function Reference Intervals by Age, Sex, and Race : A Cross-Sectional StudyQihang Li, Yida Tang, Xuefeng Yu, et al.
Radiology|June 1, 2021
Percutaneous Transhepatic Papillary Balloon Dilation versus Endoscopic Retrograde Cholangiopancreatography for Common Bile Duct Stones: A Multicenter Prospective StudyBin Liu, Jijun Ma, Shengyong Li, et al.
Blood|June 24, 2020
Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusionXinyi Xia, Kening Li, Lingxiang Wu, et al.
Nature Cell Biology|June 5, 2019
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilitiesJean-Philippe Coppé, Miki Mori, Bo Pan, et al.
Plos Medicine|April 6, 2006
Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2Jiaqi Tang, Changjun Wang, Youjun Feng, et al.
Cell Discovery|September 1, 2021
Genome-wide association study of COVID-19 severity among the Chinese populationYuanfeng Li, Yuehua Ke, Xinyi Xia, et al.
Plos One|March 22, 2007
A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolatesChen Chen, Jiaqi Tang, Wei Dong, et al.
Nature Cancer|February 9, 2023
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF<sup>V600E</sup> colorectal tumorsAna Ruiz-Saenz, Chloe E Atreya, Changjun Wang, et al.
Pageof 25